Cite
HARVARD Citation
Jakate, A. et al. (2021). Effects of CYP3A4 and P-glycoprotein inhibition or induction on the pharmacokinetics of ubrogepant in healthy adults: Two phase 1, open-label, fixed-sequence, single-center, crossover trials. Cephalalgia reports. p. . [Online].